Physician

Daniel Fred Goodman, M.D.

According to 2025 Medicare claims, Daniel Goodman, M.D. (NPI: 1679758635) practices ophthalmology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Francisco, CA. This provider's primary affiliated billing organization is DANIEL F GOODMAN, MD, A MEDICAL GROUP INC. (NPI: 1265520993; TIN: 943333741) and primary practice location at 94115-3121.

Goodman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,379 traditional Medicare patients, billed 4,734 HCPCS/CPT codes, and received $478,193 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 580 prescription claims across 203 beneficiaries totaling $128,754 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 21 records totaling $512. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $346,102 to $128,754. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$247K$493K2015 Medicare payment: $447,933 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $434,892 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $435,269 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $493,153 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $444,493 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $260,794 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $390,721 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $431,283 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $450,591 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $478,193 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2163,812$447,933
20161,2693,777$434,892
20171,2433,576$435,269
20181,3393,967$493,153
20191,3403,820$444,493
20209092,434$260,794
20211,1163,748$390,721
20221,2754,340$431,283
20231,3324,519$450,591
20241,3794,734$478,193

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$237K$473K2015 Drug cost: $346,102 (USD; Tot_Drug_Cst)2016 Drug cost: $322,511 (USD; Tot_Drug_Cst)2017 Drug cost: $379,826 (USD; Tot_Drug_Cst)2018 Drug cost: $452,695 (USD; Tot_Drug_Cst)2019 Drug cost: $473,115 (USD; Tot_Drug_Cst)2020 Drug cost: $464,054 (USD; Tot_Drug_Cst)2021 Drug cost: $373,346 (USD; Tot_Drug_Cst)2022 Drug cost: $315,236 (USD; Tot_Drug_Cst)2023 Drug cost: $147,715 (USD; Tot_Drug_Cst)2024 Drug cost: $128,754 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154392,473$346,102
20164672,290$322,511
20175022,484$379,826
20185402,852$452,695
20194962,424$473,115
20204252,167$464,054
20213981,882$373,346
20222751,033$315,236
2023229664$147,715
2024203580$128,754

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,0871,419$109
92012Established patient problem focused exam of visual system439686$82
92134Imaging of retina356397$36
92250Photography of the retina390425$33
92133Imaging of optic nerve385409$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine381,485$29,402
XiidraLifitegrast131,080$23,717
CequaCyclosporine21915$17,957
CyclosporineCyclosporine12930$13,606
Prednisolone AcetatePrednisolone Acetate873,866$3,997

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$512Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Fred Goodman, M.D.?

Tedicare shows public-source Medicare data for Daniel Fred Goodman, M.D. (NPI 1679758635), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Fred Goodman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Fred Goodman, M.D.?

Daniel Fred Goodman, M.D. is linked to DANIEL F GOODMAN, MD, A MEDICAL GROUP INC. (billing NPI 1265520993) in the available physician profile data.

Does Daniel Fred Goodman, M.D. have Open Payments data?

Daniel Fred Goodman, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.